Episode 82
NELL-1: Sanjeev Sethi, M.D., Ph.D.
Sanjeev Sethi, M.D., Ph.D., explains Mayo Clinic Laboratories’ newly developed test to detect neural epidermal growth factor-like 1 protein (NELL-1), a biomarker for membranous nephropathy (MN). The immunohistochemistry assay examines tissue samples for N
June 15, 202117m 42s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Sanjeev Sethi, M.D., Ph.D., explains Mayo Clinic Laboratories’ newly developed test to detect neural epidermal growth factor-like 1 protein (NELL-1), a biomarker for membranous nephropathy (MN). The immunohistochemistry assay examines tissue samples for NELL-1 antigen, which are found in 10% to 15% of MN patients. Discovered by Dr. Sethi in 2017, NELL-1 is the second most common antigen associated with MN and is correlated with underlying malignancy.
Topics
Primary membranous nephropathyglomerulusproteinurianephrotic syndromeNELL-1 antibodiesimmunohistochemistrykidney pathologyrenal disease